Elutia (ELUT) Research Hub

Elutia (ELUT) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 0.798 USD (-4.72%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 0.75, market cap 0.04B. This hub links to the full technical, earnings and options research available for ELUT.

Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Biotechnology)
ExchangeNASDAQ, US
Last close0.798 USD (-4.72%)
52-week range0.67 USD – 1.07 USD
Trend regimeRange
14-day RSI53.1 (Neutral)
Trailing P/E0.75
Market cap0.04B
Dividend yield0.00%
Next earnings2026-08-14

Available research for ELUT

Earnings

ELUT earnings date and last-quarter result: next report 2026-08-14, last quarter miss, P/E 0.75. Updated 2026-07-23.

Options: Covered Call

Covered Call on ELUT: how it works, illustrative setup around the real 0.798 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on ELUT: how it works, illustrative setup around the real 0.798 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on ELUT: how it works, illustrative setup around the real 0.798 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

ELUT technical analysis: range, last 0.798 USD, RSI 53.1, 52w range 0.67 USD–1.07 USD, real support/resistance. Updated 2026-10-26.

More on SniperIQ

Frequently asked questions

What sector is ELUT in?

Elutia (ELUT) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.

Is ELUT in an uptrend or downtrend?

As of 2026-10-26, ELUT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is ELUT's trailing P/E ratio?

ELUT's trailing P/E is 0.75, with a market cap of 0.04B. See the earnings research page for full valuation detail.

When does ELUT next report earnings?

ELUT is next scheduled to report earnings on 2026-08-14.